Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach
Open Access
- 1 December 2016
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 244, 98-107
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melinda Gates Foundation (OPP1130379, OPP1055855)
This publication has 24 references indexed in Scilit:
- Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activityJournal of Nanobiotechnology, 2013
- Poly(I:C)/Alum Mixed Adjuvant Priming Enhances HBV Subunit Vaccine-Induced Immunity in Mice When Combined with Recombinant Adenoviral-Based HBV Vaccine BoostingPLOS ONE, 2013
- Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine inductionVaccine, 2011
- Programming the magnitude and persistence of antibody responses with innate immunityNature, 2011
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosisScience Translational Medicine, 2010
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive ImmunityThe Journal of Immunology, 2009
- Enhanced antibody production in mice to the malaria antigen AMA1 by CPG 7909 requires physical association of CpG and antigenVaccine, 2007
- Expression and Characterization of a Single-Chain Polypeptide Analogue of the Human Immunodeficiency Virus Type 1 gp120-CD4 Receptor ComplexJournal of Virology, 2000
- Development of a Topically Active Imiquimod FormulationPharmaceutical Development and Technology, 1999
- Immunological notes. XVII–XXIVThe Journal of Pathology and Bacteriology, 1926